---
name: BioPharma Services Inc.
slug: biopharmaservices
site: cro
website_domain: biopharmaservices.com
summary: Full-service Phase 1 CRO specializing in early-stage clinical trials, bioequivalence/bioavailability studies, and human abuse potential assessments with state-of-the-art facilities in Toronto and in-house bioanalytical labs. Headquartered in Toronto, Canada.
tagline: Early-stage clinical research partner from protocol development to regulatory submission.
founded_year: 
employee_count_band: 
employee_count_label: 
parent_name: 
parent_slug: 
hq_country: CA
tier2_domain_verified: false
updated_at: 2026-10-04T07:01:00.683Z
services_count: 10
modalities_count: 1
indications_count: 4
locations_count: 1
review_signal_gate: closed
generated_by: BioBM Editorial AI
---

# BioPharma Services Inc.

Early-stage clinical research partner from protocol development to regulatory submission.

Listed on cro.directory.

## Summary

Full-service Phase 1 CRO specializing in early-stage clinical trials, bioequivalence/bioavailability studies, and human abuse potential assessments with state-of-the-art facilities in Toronto and in-house bioanalytical labs. Headquartered in Toronto, Canada.

## At a glance

- HQ country: CA

## Services

- Phase I Clinical Trials
- Phase II Clinical Trials
- Bioanalysis
- Biostatistics & Statistical Programming
- Data Management & eClinical
- Regulatory Affairs
- LC-MS Bioanalysis (Small Molecule)
- Medical Writing
- Clinical Operations
- US FDA Regulatory Strategy

## Modalities

- Small Molecule

## Indications

- Neurology
- Cardiovascular
- Immunology
- Infectious Disease

## Locations

- Headquarters & Clinical Research Facility, Toronto, Ontario, Canada

## Certifications

- Standards Council of Canada; Identifier: GLP certified; Source: https://biopharmaservices.com/about

## Long description

## Overview

BioPharma Services is a full-service contract research organization (CRO) founded by two surgeons dedicated to advancing medical science. The company specializes in early-stage clinical drug development, with particular expertise in Phase 1 and Phase 2a clinical trials.

## Core Services

**Clinical Trial Services:**
- Phase 1 and Phase 2a clinical trials across diverse therapeutic areas
- Bioequivalence (BE) and Bioavailability (BA) studies for generic and hybrid drug filings and 505(b)(2) New Drug Applications
- Human Abuse Potential (HAP) studies with extensive experience in opioids, narcotics, and cannabinoid products
- Abuse Deterrent Formulation assessments
- Psychedelic clinical trials (psilocybin, psilocin, high and microdosing studies)
- PET clinical trials and molecular imaging studies
- First-in-human (FIH) and single ascending dose (SAD) studies
- Multiple ascending dose (MAD) studies
- Food effect studies
- Proof of concept studies

**Support Services:**
- Bioanalysis and bioanalytical testing with LC/MS/MS platforms
- Data management and CDISC standards compliance
- Medical writing
- Clinical biostatistics and biometrics
- Pharmacokinetics (PK) and pharmacodynamics (PD) analysis
- Scientific affairs consultation
- Subject recruitment from extensive volunteer database including special populations
- Trial protocol development

## Facilities & Infrastructure

- State-of-the-art clinical research facility in Toronto, Ontario with 150–200 bed capacity
- In-house bioanalytical laboratory equipped with latest LC/MS/MS platforms
- Conducted approximately 2,500 bioequivalence and Phase I clinical trials
- Experience across therapeutic areas including neurology, cardiology, immunotherapies, and infectious diseases

## Regulatory & Quality

- GCP and GLP compliant operations
- GLP certified by the Standards Council of Canada (SCC)
- History of successful regulatory inspections by US FDA, UK MHRA, ANSM, DKMA, ANVISA, Health Canada, and WHO
- Adherence to ICH principles
- Proven expedited timelines including First-to-File services for US FDA submissions

## Related companies

- [Lindus Health](/companies/lindus-health) (Phase I Clinical Trials, Phase II Clinical Trials) — [Compare](/compare/biopharmaservices/lindus-health)
- [Innovate Research](/companies/innovate-research) (Phase I Clinical Trials, Phase II Clinical Trials) — [Compare](/compare/biopharmaservices/innovate-research)
- [JSS Medical Research](/companies/jssresearch) (Phase I Clinical Trials, Phase II Clinical Trials) — [Compare](/compare/biopharmaservices/jssresearch)
- [Krescent Medical Research](/companies/krescentmr) (Phase I Clinical Trials, Phase II Clinical Trials) — [Compare](/compare/biopharmaservices/krescentmr)
- [PharPoint Research](/companies/pharpoint) (Phase I Clinical Trials, Phase II Clinical Trials) — [Compare](/compare/biopharmaservices/pharpoint)
- [ClinActis Pte Ltd](/companies/clinactis) (Phase I Clinical Trials, Phase II Clinical Trials) — [Compare](/compare/biopharmaservices/clinactis)
- [Celerion](/companies/celerion) (Phase I Clinical Trials, Phase II Clinical Trials) — [Compare](/compare/biopharmaservices/celerion)
- [SPRIM PRO](/companies/sprim-pro) (Phase I Clinical Trials, Phase II Clinical Trials) — [Compare](/compare/biopharmaservices/sprim-pro)

_Profile last updated: 2026-10-04T07:01:00.683Z. Profile facts may include AI-assisted enrichment._

Auto-generated by BioBM Editorial AI for machine-readable profile access.